These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 10692263

  • 1. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.
    Ruggenenti P, Mosconi L, Vendramin G, Moriggi M, Remuzzi A, Sangalli F, Remuzzi G.
    Am J Kidney Dis; 2000 Mar; 35(3):381-91. PubMed ID: 10692263
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome.
    Kosmadakis G, Filiopoulos V, Georgoulias C, Tentolouris N, Michail S.
    Scand J Urol Nephrol; 2010 Sep; 44(4):251-6. PubMed ID: 20201749
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy.
    Remuzzi A, Perticucci E, Ruggenenti P, Mosconi L, Limonta M, Remuzzi G.
    Kidney Int; 1991 Jun; 39(6):1267-73. PubMed ID: 1716713
    [Abstract] [Full Text] [Related]

  • 4. Enalapril can treat the proteinuria of membranous glomerulonephritis without detriment to systemic or renal hemodynamics.
    Thomas DM, Hillis AN, Coles GA, Davies M, Williams JD.
    Am J Kidney Dis; 1991 Jul; 18(1):38-43. PubMed ID: 1712151
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin-converting enzyme inhibition ameliorates the defect in glomerular size selectivity in hyponatremic hypertensive syndrome.
    Remuzzi A, Schieppati A, Battaglia C, Remuzzi G.
    Am J Kidney Dis; 1989 Sep; 14(3):170-7. PubMed ID: 2476029
    [Abstract] [Full Text] [Related]

  • 6. Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome.
    Zietse R, Wenting GJ, Kramer P, Schalekamp MA, Weimar W.
    Clin Sci (Lond); 1992 Jun; 82(6):641-50. PubMed ID: 1320544
    [Abstract] [Full Text] [Related]

  • 7. Mechanism of the antiproteinuric effect of cyclosporine in membranous nephropathy.
    Ambalavanan S, Fauvel JP, Sibley RK, Myers BD.
    J Am Soc Nephrol; 1996 Feb; 7(2):290-8. PubMed ID: 8785399
    [Abstract] [Full Text] [Related]

  • 8. Nephropathy of cyanotic congenital heart disease: clinical characteristics and effectiveness of an angiotensin-converting enzyme inhibitor.
    Fujimoto Y, Matsushima M, Tsuzuki K, Okada M, Shibata M, Yanase Y, Usui K, Nagashima M.
    Clin Nephrol; 2002 Aug; 58(2):95-102. PubMed ID: 12227694
    [Abstract] [Full Text] [Related]

  • 9. The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
    Zoja C, Donadelli R, Corna D, Testa D, Facchinetti D, Maffi R, Luzzana E, Colosio V, Bertani T, Remuzzi G.
    Am J Kidney Dis; 1997 Feb; 29(2):254-64. PubMed ID: 9016898
    [Abstract] [Full Text] [Related]

  • 10. The antiproteinuric effect of angiotensin antagonism in human IgA nephropathy is potentiated by indomethacin.
    Perico N, Remuzzi A, Sangalli F, Azzollini N, Mister M, Ruggenenti P, Remuzzi G.
    J Am Soc Nephrol; 1998 Dec; 9(12):2308-17. PubMed ID: 9848785
    [Abstract] [Full Text] [Related]

  • 11. The influence of angiotensin-converting enzyme inhibition on renal tubular function in progressive chronic nephropathy.
    Kamper AL, Holstein-Rathlou NH, Leyssac PP, Strandgaard S.
    Am J Kidney Dis; 1996 Dec; 28(6):822-31. PubMed ID: 8957033
    [Abstract] [Full Text] [Related]

  • 12. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
    Lancet; 1997 Jun 28; 349(9069):1857-63. PubMed ID: 9217756
    [Abstract] [Full Text] [Related]

  • 13. [Renal hemodynamics and proteinuria in chronic glomerulonephritis treated with beta-receptor blockers or ace inhibitors].
    Erley CM, Berger ED, Heyne N, Klass M, Krämer D, Braun N, Wolf S, Risler T.
    Dtsch Med Wochenschr; 1997 Aug 01; 122(31-32):953-8. PubMed ID: 9280714
    [Abstract] [Full Text] [Related]

  • 14. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.
    Bazzi C, Usui T, Rizza V, Casellato D, Gallieni M, Nangaku M.
    Nephrology (Carlton); 2018 Feb 01; 23(2):175-182. PubMed ID: 27764902
    [Abstract] [Full Text] [Related]

  • 15. Renal hemodynamics and reduction of proteinuria by a vasodilating beta blocker versus an ACE inhibitor.
    Erley CM, Harrer U, Krämer BK, Risler T.
    Kidney Int; 1992 May 01; 41(5):1297-303. PubMed ID: 1614045
    [Abstract] [Full Text] [Related]

  • 16. Comparative effects of antihypertensives on proteinuria: angiotensin-converting enzyme inhibitor versus alpha 1-antagonist.
    Rosenberg ME, Hostetter TH.
    Am J Kidney Dis; 1991 Oct 01; 18(4):472-82. PubMed ID: 1656730
    [Abstract] [Full Text] [Related]

  • 17. ACE inhibition and ANG II receptor blockade improve glomerular size-selectivity in IgA nephropathy.
    Remuzzi A, Perico N, Sangalli F, Vendramin G, Moriggi M, Ruggenenti P, Remuzzi G.
    Am J Physiol; 1999 Mar 01; 276(3):F457-66. PubMed ID: 10070170
    [Abstract] [Full Text] [Related]

  • 18. Pathological predictors of renal outcomes in nephrotic idiopathic membranous nephropathy with decreased renal function.
    Chen Y, Tang L, Feng Z, Cao X, Sun X, Liu M, Liu S, Zhang X, Li P, Wei R, Qiu Q, Cai G, Chen X.
    J Nephrol; 2014 Jun 01; 27(3):307-16. PubMed ID: 24523071
    [Abstract] [Full Text] [Related]

  • 19. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
    Liang Q, Li H, Xie X, Qu F, Li X, Chen J.
    Ren Fail; 2017 Nov 01; 39(1):512-518. PubMed ID: 28562168
    [Abstract] [Full Text] [Related]

  • 20. Factors affecting the long-term outcomes of idiopathic membranous nephropathy.
    Huh H, Lee H, Lee JP, Kim DK, Oh S, Oh YK, Kim YS, Lim CS.
    BMC Nephrol; 2017 Mar 27; 18(1):104. PubMed ID: 28347297
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.